ATE486860T1 - Phenothiazin-derivat zur wundheilung - Google Patents

Phenothiazin-derivat zur wundheilung

Info

Publication number
ATE486860T1
ATE486860T1 AT05782564T AT05782564T ATE486860T1 AT E486860 T1 ATE486860 T1 AT E486860T1 AT 05782564 T AT05782564 T AT 05782564T AT 05782564 T AT05782564 T AT 05782564T AT E486860 T1 ATE486860 T1 AT E486860T1
Authority
AT
Austria
Prior art keywords
wound healing
phenothiazine derivative
skin
wound site
phenothiazinium compound
Prior art date
Application number
AT05782564T
Other languages
English (en)
Inventor
Stanley Beames Brown
Cassandra Clare O'grady
Original Assignee
Photopharmica Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photopharmica Ltd filed Critical Photopharmica Ltd
Application granted granted Critical
Publication of ATE486860T1 publication Critical patent/ATE486860T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B5/00—Dyes with an anthracene nucleus condensed with one or more heterocyclic rings with or without carbocyclic rings
    • C09B5/24—Dyes with an anthracene nucleus condensed with one or more heterocyclic rings with or without carbocyclic rings the heterocyclic rings being only condensed with an anthraquinone nucleus in 1-2 or 2-3 position
    • C09B5/44—Azines of the anthracene series
    • C09B5/60—Thiazines; Oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18—[b, e]-condensed with two six-membered rings
    • C07D279/22—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom
    • C07D279/24—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom with hydrocarbon radicals, substituted by amino radicals, attached to the ring nitrogen atom
    • C07D279/28—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom with hydrocarbon radicals, substituted by amino radicals, attached to the ring nitrogen atom with other substituents attached to the ring system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT05782564T 2004-09-20 2005-09-14 Phenothiazin-derivat zur wundheilung ATE486860T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0420888A GB0420888D0 (en) 2004-09-20 2004-09-20 Compounds and uses
PCT/GB2005/003536 WO2006032847A1 (en) 2004-09-20 2005-09-14 Wound healing

Publications (1)

Publication Number Publication Date
ATE486860T1 true ATE486860T1 (de) 2010-11-15

Family

ID=33306894

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05782564T ATE486860T1 (de) 2004-09-20 2005-09-14 Phenothiazin-derivat zur wundheilung

Country Status (11)

Country Link
US (3) US7407953B2 (de)
EP (1) EP1797053B1 (de)
JP (1) JP5118967B2 (de)
AT (1) ATE486860T1 (de)
CY (1) CY1111177T1 (de)
DE (1) DE602005024590D1 (de)
DK (1) DK1797053T3 (de)
ES (1) ES2358760T3 (de)
GB (1) GB0420888D0 (de)
PT (1) PT1797053E (de)
WO (1) WO2006032847A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0113121D0 (en) * 2001-05-30 2001-07-18 Univ Leeds Biologically active photosensitisers
US8188224B2 (en) 2005-04-11 2012-05-29 Savient Pharmaceuticals, Inc. Variant forms of urate oxidase and use thereof
JP5366553B2 (ja) 2005-11-09 2013-12-11 クロックス テクノロジーズ インコーポレイテッド 歯のホワイトニング組成物及び方法
EP2368597A1 (de) 2006-04-28 2011-09-28 Ondine International Holdings Ltd. Photodesinfektionsvorrichtung und Verfahren
US20100266989A1 (en) 2006-11-09 2010-10-21 Klox Technologies Inc. Teeth whitening compositions and methods
KR20150072458A (ko) * 2006-11-15 2015-06-29 코다 테라퓨틱스, 인크. 상처 치유를 위한 개선 방법 및 조성물
CN101631780A (zh) * 2007-04-03 2010-01-20 普罗瑟塔生物谐成公司 用于抗病毒治疗的吩噻嗪衍生物
BRPI0801368A8 (pt) * 2008-05-12 2021-03-23 Fund De Amparo A Pesquisa Do Estado De Sao Paulo Fapesp processos de estabilização de radicais cátion de compostos fenotiazínicos, formulações cosmecêuticas, usos de compostos fenotiazínicos na preparação de formulações cosmecêuticas e métodos de prevenção de doenças e distúrbios de pele
NZ592651A (en) * 2008-11-07 2013-05-31 Klox Technologies Inc Oxidatitive photoactivated skin rejeuvenation composition comprising hyaluronic acid, glucosamine, or allantoin
US20100166677A1 (en) 2008-12-30 2010-07-01 Avon Products, Inc. Use of Tiliacora Triandra in Cosmetics and Compositions Thereof
EP4635567A3 (de) 2009-06-25 2025-12-03 Horizon Therapeutics USA, Inc. Verfahren und kits zur prävention des infusionsreaktionsrisikos und antikörpervermittelter reaktionsverlust durch überwachung von serumharnsäure während der pegylierten harnasetherapie
CN102548576A (zh) * 2009-06-25 2012-07-04 萨文特制药公司 在痛风石性痛风治疗中评估降尿酸治疗期间痛风石响应的方法
PL2453922T3 (pl) 2009-07-17 2018-03-30 Klox Technologies Inc. Przeciwbakteryjna doustna kompozycja
EP2515869B1 (de) * 2009-12-22 2018-03-14 Rigshospitalet, Copenhagen University Hospital Wundpflegeprodukte
CN102958525B (zh) 2010-04-30 2017-05-24 普罗瑟塔抗病毒股份有限公司 抗病毒化合物
CA2799223C (en) 2010-06-30 2019-02-26 Avon Products, Inc. Compositions and methods for stimulating magp-1 to improve the appearance of skin
WO2012125983A1 (en) 2011-03-17 2012-09-20 Prosetta Antiviral Inc. Antiviral treatments
WO2012145567A1 (en) 2011-04-20 2012-10-26 Prosetta Antiviral Inc. Antiviral compounds
US20120301904A1 (en) 2011-04-26 2012-11-29 Prosetta Antiviral, Inc Multiprotein assemblies
US20130103123A1 (en) 2011-10-14 2013-04-25 Sazzadur Rahman Khan Light-Emitting Devices for Wound Healing
EP2833876A4 (de) * 2012-04-02 2015-09-09 Health Research Inc Zusammensetzungen und verfahren mit toll-like rezeptor (tlr)-stimulierenden wirkstoffe zur prophylaxe und therapie von schäden des dermalen epithels
US20130281913A1 (en) 2012-04-20 2013-10-24 Klox Technologies Inc. Biophotonic compositions and methods for providing biophotonic treatment
US11116841B2 (en) 2012-04-20 2021-09-14 Klox Technologies Inc. Biophotonic compositions, kits and methods
EP2895139B1 (de) 2012-09-14 2019-10-23 Bausch Health Companies Inc. Verfahren zur zahnbleichung
CA2891291A1 (en) 2012-11-12 2014-05-15 Moontunes, Inc. Systems and methods for communicating a live event to users using the internet
US20140276354A1 (en) 2013-03-14 2014-09-18 Klox Technologies Inc. Biophotonic materials and uses thereof
US10272096B2 (en) 2013-06-07 2019-04-30 The Regents Of The University Of California Methods and systems of treating wounds
HK1219890A1 (zh) 2013-07-03 2017-04-21 广东科洛克生物医药集团有限公司 治疗不癒合伤口的组合物和方法
US20150065943A1 (en) * 2013-08-27 2015-03-05 Matthew DeBow Method to Accelerate Healing
JP2017509433A (ja) 2014-04-01 2017-04-06 クロックス テクノロジーズ インコーポレイテッドＫｌｏｘ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｉｎｃ． 組織充填剤組成物および使用方法
US10153510B2 (en) 2014-06-23 2018-12-11 University Of Kentucky Research Foundation Non-aqueous redox flow batteries including 3,7-perfluoroalkylated phenothiazine derivatives
CA2958879A1 (en) 2014-08-22 2016-02-25 Auckland Uniservices Limited Channel modulators
RU2017117187A (ru) 2014-10-31 2018-11-30 Клокс Текнолоджиз Инк. Фотоактивируемые волокна и тканые материалы
US20200237881A1 (en) 2019-01-30 2020-07-30 Horizon Pharma Rheumatology Llc Reducing immunogenicity to pegloticase
CN110234340A (zh) 2016-11-11 2019-09-13 好利恩风湿病制药有限责任公司 泼尼松和尿酸酶分子的组合疗法及其用途
US12121566B2 (en) 2019-01-30 2024-10-22 Horizon Therapeutics Usa, Inc. Methods for treating gout
WO2023229659A2 (en) * 2021-10-21 2023-11-30 The General Hospital Corporation Photonic antimicrobial wound surface dressing
US12269875B2 (en) 2023-08-03 2025-04-08 Jeff R. Peterson Gout flare prevention methods using IL-1BETA blockers

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE488945C (de) * 1924-09-12 1930-01-25 I G Farbenindustrie Akt Ges Verfahren zur Darstellung von Aminoalkylaminosubstitutionsprodukten der Azin-, Oxazin- und Thiazinreihe
WO1993021992A1 (en) 1992-04-30 1993-11-11 Institute Of Dental Surgery Laser treatment
DE4220736A1 (de) * 1992-06-25 1994-01-05 Puetter Medice Chem Pharm Einschlußkomplexe aus polymerisierten Cyclodextrinen mit pharmazeutisch aktiven Wirkstoffen
US5913884A (en) * 1996-09-19 1999-06-22 The General Hospital Corporation Inhibition of fibrosis by photodynamic therapy
CA2298526A1 (en) * 1997-07-28 1999-02-04 Dermatolazer Technologies Ltd Phototherapy based method for treating pathogens and composition for effecting same
WO2000030630A1 (en) 1998-11-23 2000-06-02 Linden Biotechnology, Inc. Combination products of a guanylate cyclase inhibitor and a local anesthetic for pain relief
WO2000040277A1 (en) * 1999-01-08 2000-07-13 Browdie David A Tissue adhesive for treating vigorously bleeding surfaces
CN1108156C (zh) 1999-03-26 2003-05-14 夏志陶 一种主要用于手术后创口及外伤伤口的长效止痛剂
US6420455B1 (en) * 1999-06-18 2002-07-16 3M Innovative Properties Company Antimicrobial composition containing photosensitizers articles, and methods of use
US7073510B2 (en) 2000-02-11 2006-07-11 The General Hospital Corporation Photochemical tissue bonding
EP1272119B1 (de) 2000-02-11 2010-11-24 The General Hospital Corporation Photochemische gewebeverbindung
GB0113121D0 (en) * 2001-05-30 2001-07-18 Univ Leeds Biologically active photosensitisers
GB0118251D0 (en) * 2001-07-26 2001-09-19 Photocure Asa Method

Also Published As

Publication number Publication date
PT1797053E (pt) 2011-02-09
EP1797053B1 (de) 2010-11-03
US20070161625A1 (en) 2007-07-12
JP2008513424A (ja) 2008-05-01
JP5118967B2 (ja) 2013-01-16
US7407953B2 (en) 2008-08-05
DK1797053T3 (da) 2011-02-21
DE602005024590D1 (de) 2010-12-16
GB0420888D0 (en) 2004-10-20
WO2006032847A1 (en) 2006-03-30
ES2358760T3 (es) 2011-05-13
US20110028459A1 (en) 2011-02-03
CY1111177T1 (el) 2015-06-11
US20090023715A1 (en) 2009-01-22
EP1797053A1 (de) 2007-06-20

Similar Documents

Publication Publication Date Title
ATE486860T1 (de) Phenothiazin-derivat zur wundheilung
BRPI0607762B8 (pt) análogos de glp-1, composição farmacêutica contendo os mesmos e uso de um composto
CY2016031I1 (el) Τοπικη φαρμακοτεχνικη μορφη ιβερμεκτινης για την θεραπεια δερματολογικων καταστασεων
BR0308429A (pt) Aroilpiridinonas monocìclicas como agentes antiinflamatórios
ATE516037T1 (de) Topische formulierung von ivermectin zur behandlung von dermatologischen erkrankungen
CY1106386T1 (el) Υποκατεστημενα παραγωγα 3-πυρρολιδιν-ινδολης
ATE361084T1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
DK1651161T3 (da) Farmaceutiske præparater og fremgangsmåder til at fremme sårheling
BRPI0408476A (pt) métodos para melhorar a qualidade da pele
BR0308928A (pt) Uso de toxina botulìnica para o tratamento de doenças cardiovasculares, bem como composição para uso em um procedimento cardiovascular
DK1565136T3 (da) Sammensætninger for transdermal oxybutynin-terapi
SE0301882D0 (sv) New use I
DK1307227T3 (da) Farmaceutiske sammensætninger
CY2018006I2 (el) Θεραπευτικο σχημα κλαδριβινης για την θεραπευτικη αντιμετωπιση της σκληρυνσης κατα πλακας
EA200601777A1 (ru) Новое применение пептидных соединений для лечения боли при болезненной диабетической нейропатии
NO20071798L (no) Dermalt pafore formuleringer for behandling av hudsykdommer i dyr
ECSP045493A (es) Nuevas composiciones farmacéuticas que contienen flibanserina polimorfo a
CY1120368T1 (el) Αλληλουχια ειδικης διασπασης μμρ-14
WO2007030666A3 (en) Medicated skin care preparation for promoting wound healing
FR2846239B1 (fr) Composition de cosmetique destinee a blanchir la peau comprenant du senkyunolide a en tant que principe actif
EA200601288A1 (ru) Производные 1,3-дифенилпроп-2-ен-1-она, способ их получения и применение
PA8571401A1 (es) Imidazolinilmetil aralquilsulfonamidas
BRPI0418764A (pt) uso de espinosina ou um derivado ou sal da mesma fisiologicamente aceitável
CY1111361T1 (el) Νεα προσδεματα συναγωνιστες των υποδοχεων rar, χρηση στην ανθρωπινη ιατρικη καθως και στην κοσμετολογια
SE0301883D0 (sv) New use II

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1797053

Country of ref document: EP